Localized adenovirus gene delivery using antiviral IgG complexation

Area of Science:

• Biotechnology
• Gene Therapy
• Materials Science

Background:

• Gene therapy using viral vectors is advancing but faces challenges in targeted delivery.
• Localized delivery is crucial for enhancing therapeutic efficacy and minimizing off-target effects.

Purpose of the Study:

• To develop and validate a novel antibody-based system for localized adenoviral vector delivery.
• To investigate the stability, localization, and therapeutic potential of antibody-complexed viral vectors in a biodegradable matrix.

Main Methods:

• Antibody immobilization of adenoviral vectors onto a type I collagen-avidin gel using biotinylated IgG specific for the adenovirus hexon.
• In vitro stability and activity assays of antibody-complexed viral vectors.
• Cell culture studies using reporter and therapeutic adenoviral vectors for localized gene transduction and cell killing.
• In vivo myocardial gene transfer studies in pigs.

Main Results:

• Antibody-complexed adenovirus in collagen gels retained viral activity, unlike non-specific controls.
• Localized reporter gene expression (beta-galactosidase) was significantly enhanced in cell cultures.
• Targeted cell killing (HSVtk) was achieved within 50 micrometers with antibody-complexed vectors, contrasting with widespread cell death in controls.
• Improved adenoviral GFP expression in pig hearts via antibody-complexed matrix injection compared to direct injection.

Conclusions:

• Antibody-complexation of adenoviral vectors onto a biodegradable matrix enables site-specific localization of gene delivery.
• This approach enhances therapeutic vector efficiency and minimizes distal side effects.
• The developed system holds potential as an implantable preparation for localized and optimized viral vector gene therapy.